Alexandria Real Estate Equities
ARE
#2388
Rank
C$10.77 B
Marketcap
C$61.82
Share price
-2.60%
Change (1 day)
-39.08%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -C$0.84 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are C$2.85 Billion. In 2025 the company made an earning of -C$1.37 Billion a decrease over its 2024 earnings that were of C$0.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.84 Billion-38.42%
2025 -C$1.37 Billion-242.13%
2024 C$0.95 B96.11%
2023 C$0.48 B-53.56%
2022 C$1.05 B-3.96%
2021 C$1.09 B-20.26%
2020 C$1.37 B72.88%
2019 C$0.79 B3.11%
2018 C$0.77 B73.54%
2017 C$0.44 B464.88%
2016 C$78.56 M-77.32%
2015 C$0.34 B36.31%
2014 C$0.25 B-10.81%
2013 C$0.28 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.55 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.78 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.49 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.46 B-1,688.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.59 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.19 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.19 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA